Standout Papers

Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a pha... 2001 2026 2009 2017 959
  1. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study (2001)
    Allan T. van Oosterom, Ian Judson et al. The Lancet
  2. Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's Disease (2005)
    Gert Van Assche, Marc Van Ranst et al. New England Journal of Medicine
  3. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours (2006)
    Maria Dêbiec‐Rychter, Raf Sciot et al. European Journal of Cancer

Immediate Impact

13 by Nobel laureates 8 from Science/Nature 79 standout
Sub-graph 1 of 19

Citing Papers

A role of PIEZO1 in iron metabolism in mice and humans
2021 StandoutNobel
Eribulin versus dacarbazine in previously treated patients with advanced liposarcoma or leiomyosarcoma: a randomised, open-label, multicentre, phase 3 trial
2016 Standout
3 intermediate papers

Works of Raf Sciot being referenced

Activity of eribulin mesylate in patients with soft-tissue sarcoma: a phase 2 study in four independent histological subtypes
2011
Imatinib Mesylate in Advanced Dermatofibrosarcoma Protuberans: Pooled Analysis of Two Phase II Clinical Trials
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
Raf Sciot 11789 5555 5126 544 23.7k
Brian P. Rubin 10841 3582 4148 273 18.7k
Pancras C.W. Hogendoorn 14667 9073 6689 436 25.2k
Robert G. Maki 17885 3606 9578 377 25.7k
Masazumi Tsuneyoshi 8170 3395 7475 574 21.9k
Christopher L. Corless 16635 2767 5773 318 30.3k
Raphael E. Pollock 10885 3691 7681 345 17.9k
Heikki Joensuu 11879 1383 12609 570 34.2k
Yoshinao Oda 7481 2224 8452 936 19.8k
Silvana Pilotti 5255 2219 6524 293 15.9k
Elizabeth A. Montgomery 4874 2522 3445 328 15.3k

All Works

Loading papers...

Rankless by CCL
2026